Robotic Vs Laparoscopic Distal Gastrectomy for Gastric Cance
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
In a recent study, investigators found that robotic distal gastrectomy (RDG) is linked with a lower morbidity rate, faster recovery, milder inflammatory responses, and improved lymphadenectomy.

The study objective was to evaluate the short-term outcomes of patients with gastric cancer (GC) who received robotic distal gastrectomy (RDG) or laparoscopic distal gastrectomy (LDG).

300 patients with cT1-4a and N0/+ between September 2017 and January 2020 were enrolled in this randomized controlled trial at a high-volume hospital in China. The short-term outcomes were compared between the groups.

The modified intention-to-treat analysis included data from 283 patients (RDG group: n = 141) and (LDG group: n = 142).

--Patients in the RDG group exhibited faster postoperative recovery, milder inflammatory responses, and reduced postoperative morbidity.

--Higher extraperigastric lymph nodes (LNs) were retrieved in the RDG group with a lower non-compliance rate.

--Additionally, patients in the RDG group were more likely to initiate adjuvant chemotherapy earlier.

--Although total hospital costs were higher in the robotic group than in the laparoscopic group, the direct cost was lower for RDG than for LDG.

RDG is associated with a lower morbidity rate, faster recovery, milder inflammatory responses, and improved lymphadenectomy. Additionally, faster postoperative recovery in the RDG group enables early initiation of adjuvant chemotherapy. The results provide evidence for the application of RDG in patients with GC.

Source: https://journals.lww.com/annalsofsurgery/Abstract/2021/05000/Assessment_of_Robotic_Versus_Laparoscopic_Distal.7.aspx
Like
Comment
Share